Answers are grounded in this paper and cite their sources.
Introduction: Diabetic foot infections (DFIs) are a common and serious complication in individuals with diabetes mellitus. Low levels of Vitamin D have been proposed as a risk factor for diabetic foot and may be associated with cytokine dysregulation. This study aimed to evaluate the effect of Vitamin D supplementation on circulating levels of tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) in Type 2 diabetes mellitus (T2DM) patients with and without foot infections. Methods: T2DM patients with and without foot infections were enrolled as cases and controls. Both groups were supplemented with a total 300,000 IU oral dose of Vitamin D. Serum concentrations of 25 (OH) Vitamin D and cytokines (TNF-α, IL-6) were measured in both groups at baseline and follow-up using radioimmunoassay and enzyme-linked immunosorbent assay, respectively. Results: Serum concentrations of 25 (OH) Vitamin D significantly increased in both groups (cases: P <0.0001; controls: P =0.012). The difference in mean (±standard deviation) levels of circulating serum inflammatory cytokines, TNF-α and IL-6, at baseline and follow-up was not significant in controls but was significant in cases (TNF-α: P =0.0001; IL-6: P =0.0026). Conclusion: Vitamin D supplementation, particularly a high dose (60,000 IU/week) for a short period (5 weeks), significantly reduces inflammatory cytokines TNF-α and IL-6 in patients with DFI, supporting its beneficial role in managing inflammation.
No takes yet. Share an insight, caveat, or question.
Dwivedi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: